About ARC
We are accelerating the development of and access to new and innovative treatments for amyloidosis.
The Amyloidosis Research Consortium (ARC) is a global organization founded in 2015. Our mission is dedicated to changing the way research is being done and focuses on what will have the greatest impact on improving the lives of patients. We forge collaborations across industry, academia and regulatory to more rapidly advance the discovery of new treatments.
Accelerating Diagnosis
Building comprehensive programs to educate physicians and provide the tools needed to ensure that patients are diagnosed earlier.
Advancing Research
Actively collaborating with key stakeholders to shape the research environment and optimize scarce resources.
Accessible Treatment
Engaging with policy makers to improve the understanding of amyloidosis and to speed new therapies to market.
Supporting Patients
Empowering patients with innovative educational tools and support to ensure they have access to the best quality of care.
Meet the team behind the mission.
We are a team of passionate experts in the field of amyloidosis who are committed to building a better future for patients.
